173 related articles for article (PubMed ID: 19760123)
1. Chemo-radiotherapy in locally advanced squamous cell oesophageal cancer--are upper third tumours more responsive?
Papp A; Cseke L; Farkas R; Pavlovics G; Horvath G; Varga G; Szigeti A; Bellyei S; Marton S; Poto L; Kalmar K; Vereczkei A; Pozsgai E; Horvath OP
Pathol Oncol Res; 2010 Jun; 16(2):193-200. PubMed ID: 19760123
[TBL] [Abstract][Full Text] [Related]
2. [The role of neoadjuvant therapy in the treatment of locally advanced squamous cell cancer of the cervical oesophagus].
Papp A; Cseke L; Varga G; Pavlovics G; Potó L; Márton S; Farkas R; Bellyei S; Horváth OP
Magy Seb; 2012 Oct; 65(5):340-7. PubMed ID: 23086818
[TBL] [Abstract][Full Text] [Related]
3. [The effect of preoperative chemo-radiotherapy in the treatment of locally advanced squamous cell carcinoma in the upper- and middle-thirds of the esophagus].
Papp A; Cseke L; Pavlovics G; Farkas R; Varga G; Márton S; Pótó L; Esik O; Horváth OP
Magy Seb; 2007; 60(3):123-9. PubMed ID: 17727214
[TBL] [Abstract][Full Text] [Related]
4. Comparison of survival among neoadjuvant chemoradiation responders, non-responders and patients receiving primary resection for locally advanced oesophageal squamous cell carcinoma: does neoadjuvant chemoradiation benefit all?
Hsu PK; Chien LI; Huang CS; Hsieh CC; Wu YC; Hsu WH; Chou TY
Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):460-6. PubMed ID: 23728085
[TBL] [Abstract][Full Text] [Related]
5. Human epidermal growth factor receptor-2 in oesophageal cancers: an observational study.
Al-Momani H; Barnes R; El-Hadi A; Shah R; Lewis WG; Edwards P
World J Gastroenterol; 2012 Nov; 18(44):6447-51; discussion p.6450. PubMed ID: 23197890
[TBL] [Abstract][Full Text] [Related]
6. Prediction of prognosis after trimodal therapy in patients with locally advanced squamous cell carcinoma of the oesophagus.
Stahl M; Lehmann N; Walz MK; Stuschke M; Wilke H
Eur J Cancer; 2012 Nov; 48(16):2977-82. PubMed ID: 22503151
[TBL] [Abstract][Full Text] [Related]
7. Pre-treatment maximal oesophageal wall thickness is independently associated with response to chemoradiotherapy in patients with T3-4 oesophageal squamous cell carcinoma.
Li SH; Rau KM; Lu HI; Wang YM; Tien WY; Liang JL; Lin WC
Eur J Cardiothorac Surg; 2012 Dec; 42(6):958-64. PubMed ID: 22466694
[TBL] [Abstract][Full Text] [Related]
8. First-line chemotherapy improves the resection rate and long-term survival of locally advanced (T4, any N, M0) squamous cell carcinoma of the thoracic esophagus: final report on 163 consecutive patients with 5-year follow-up.
Ancona E; Ruol A; Castoro C; Chiarion-Sileni V; Merigliano S; Santi S; Bonavina L; Peracchia A
Ann Surg; 1997 Dec; 226(6):714-23; discussion 723-4. PubMed ID: 9409570
[TBL] [Abstract][Full Text] [Related]
9. Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer.
Lim SH; Hong M; Ahn S; Choi YL; Kim KM; Oh D; Ahn YC; Jung SH; Ahn MJ; Park K; Zo JI; Shim YM; Sun JM
Eur J Cancer; 2016 Jan; 52():1-9. PubMed ID: 26623522
[TBL] [Abstract][Full Text] [Related]
10. Effects of preoperative chemoradiotherapy on postsurgical morbidity and mortality in cT3-4 +/- cM1lymph cancer of the oesophagus and gastro-oesophageal junction.
Hagry O; Coosemans W; De Leyn P; Nafteux P; Van Raemdonck D; Van Cutsem E; Hausterman K; Lerut T
Eur J Cardiothorac Surg; 2003 Aug; 24(2):179-86; discussion 186. PubMed ID: 12895604
[TBL] [Abstract][Full Text] [Related]
11. Induction therapy for clinical T4 oesophageal carcinoma; a plea for continued surgical exploration.
Van Raemdonck D; Van Cutsem E; Menten J; Ectors N; Coosemans W; De Leyn P; Lerut T
Eur J Cardiothorac Surg; 1997 May; 11(5):828-37. PubMed ID: 9196296
[TBL] [Abstract][Full Text] [Related]
12. Anatomical distribution of residual cancer in patients with oesophageal squamous cell carcinoma who achieved clinically complete response after neoadjuvant chemoradiotherapy.
Chao YK; Chuang WY; Yeh CJ; Chang HK; Tseng CK
Eur J Cardiothorac Surg; 2018 Jan; 53(1):201-208. PubMed ID: 28977486
[TBL] [Abstract][Full Text] [Related]
13. Utility of restaging endoscopic ultrasound after neoadjuvant therapy for esophageal cancer.
Griffin JM; Reed CE; Denlinger CE
Ann Thorac Surg; 2012 Jun; 93(6):1855-9; discussion 1860. PubMed ID: 22516835
[TBL] [Abstract][Full Text] [Related]
14. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
15. Weekly docetaxel with concomitant radiotherapy in patients with inoperable oesophageal cancer.
Font A; Arellano A; Fernández-Llamazares J; Casas D; Boix J; Cardenal J; Margelí M; Manzano JL; Abad A; Rosell R
Clin Transl Oncol; 2007 Mar; 9(3):177-82. PubMed ID: 17403629
[TBL] [Abstract][Full Text] [Related]
16. The pre-operative treatment of oesophageal carcinoma with synchronously administered chemotherapy and radiotherapy.
Gill PG; Jamieson GG
Ann Acad Med Singap; 1992 Mar; 21(2):243-7. PubMed ID: 1519895
[TBL] [Abstract][Full Text] [Related]
17. Oesophagectomy for tumours and dysplasia of the oesophagus and gastro-oesophageal junction.
Epari K; Cade R
ANZ J Surg; 2009 Apr; 79(4):251-7. PubMed ID: 19432710
[TBL] [Abstract][Full Text] [Related]
18. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.
Schneider PM; Baldus SE; Metzger R; Kocher M; Bongartz R; Bollschweiler E; Schaefer H; Thiele J; Dienes HP; Mueller RP; Hoelscher AH
Ann Surg; 2005 Nov; 242(5):684-92. PubMed ID: 16244542
[TBL] [Abstract][Full Text] [Related]
19. Role of preoperative chemoradiation in the management of upper third thoracic esophageal squamous cell carcinoma.
Tsujinaka T; Shiozaki H; Yamamoto M; Inoue M; Yano M; Doki Y; Monden M
Am J Surg; 1999 Jun; 177(6):503-6; discussion 507. PubMed ID: 10414703
[TBL] [Abstract][Full Text] [Related]
20. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
